[LXRX] QoQ Quarter Result on 30-Sep-2022 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
09-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 5.91%
YoY- -2.41%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
Revenue 317 24 28 39 35 37 14 704.95%
PBT -44,904 -31,934 -30,494 -23,387 -24,587 -23,476 -25,611 45.55%
Tax 1,152 -1,029 216 292 580 96 -14 -
NP -44,904 -30,905 -30,710 -23,679 -25,167 -23,572 -25,611 45.55%
Tax Rate - - - - - - - -
Total Cost 45,221 30,929 30,738 23,718 25,202 23,609 25,625 46.18%
Ratio Analysis
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
NP Margin -14,165.30 -128,770.83 -109,678.57 -60,715.38 -71,905.71 -63,708.11 -182,935.71 -81.91%
Per Share
30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 CAGR
EPS -0.22 -0.16 -0.16 -0.14 -0.17 -0.16 -0.17 18.81%
EPS Diluted -0.22 -0.16 -0.16 -0.14 -0.17 -0.16 -0.17 18.81%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.